State Street
ESLA icon

State Street’s Estrella Immunopharma ESLA Stock Holding History

State Street’s Portfolio ESLA Stock Details ESLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$45K Hold
43,252
– – ﹤0.01% 4066
2026
Q1 		$45.8K Hold
43,252
– – ﹤0.01% 4143
2025
Q4 		$67.5K Buy
43,252
+20,900
+94% +$39.6K ﹤0.01% 4115
2025
Q3 		$26.6K Hold
22,352
– – ﹤0.01% 4227
2025
Q2 		$19.1K Hold
22,352
– – ﹤0.01% 4204
2025
Q1 		$20.7K Hold
22,352
– – ﹤0.01% 4203
2024
Q4 		$25.3K Buy
+22,352
New +$22.5K ﹤0.01% 4211

Other funds holding ESLA

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

State Street's ESLA Position: Q2 2026 in Review

State Street held its Estrella Immunopharma (ESLA) position steady in Q2 2026 at 43,252 shares worth $45K. The position accounts for ﹤0.01% of the portfolio, ranked #4066.

State Street first reported a position in ESLA in Q4 2024 and has held it in 7 quarters since. The position peaked at $67.5K in Q4 2025. 15 funds tracked by Wall St. Rank hold ESLA as of Q2 2026.

  • State Street held 43,252 shares of Estrella Immunopharma worth $45K as of Q2 2026.
  • State Street left its Estrella Immunopharma share count unchanged in Q2 2026.
  • Estrella Immunopharma made up ﹤0.01% of State Street's portfolio in Q2 2026, its #4066 holding.
  • State Street first reported a position in Estrella Immunopharma in Q4 2024 and has held it in 7 quarters since.
  • State Street's Estrella Immunopharma position peaked at $67.5K in Q4 2025.
  • 15 funds tracked by Wall St. Rank held Estrella Immunopharma as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.